Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial

Sharman, Jeff P ; Egyed, Miklos ; Jurczak, Wojciech ; Skarbnik, Alan ; Pagel, John M ; Flinn, Ian W ; Kamdar, Manali ; Munir, Talha ; Walewska, Renata ; Corbett, Gillian ; Fogliatto, Laura Maria ; Herishanu, Yair ; Banerji, Versha ; Coutre, Steven ; Follows, George ; Walker, Patricia ; Karlsson, Karin ; Ghia, Paolo ; Janssens, Ann ; Cymbalista, Florence ; Woyach, Jennifer A ; Salles, Gilles ; Wierda, William G ; Izumi, Raquel ; Munugalavadla, Veerendra ; Patel, Priti ; Wang, Min Hui ; Wong, Sofia ; Byrd, John C

The Lancet (British edition), 2020-04, Vol.395 (10232), p.1278 [Periódico revisado por pares]

England

Texto completo disponível